Cross-Reactivity and Functionality of Approved Human Immune Checkpoint Blockers in Dogs

SIMPLE SUMMARY: Immunotherapy with immune checkpoint inhibitors (ICI) has been a major advance in the management of cancers. To increase response rates, numerous new cancer immunotherapies are under development, to be used as monotherapies or as combination with existing ICIs. Lately, companion dogs...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantelyushin, Stanislav, Ranninger, Elisabeth, Guerrera, Diego, Hutter, Gregor, Maake, Caroline, Markkanen, Enni, Bettschart-Wolfensberger, Regula, Rohrer Bley, Carla, Läubli, Heinz, vom Berg, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918463/
https://www.ncbi.nlm.nih.gov/pubmed/33668625
http://dx.doi.org/10.3390/cancers13040785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918463/
https://www.ncbi.nlm.nih.gov/pubmed/33668625
http://dx.doi.org/10.3390/cancers13040785

Ejemplares similares